glp 1 for alcohol cravings GLP1 receptor agonists are supported by preclinical and observational evidence reducing addictive behaviors, particularly and nicotine use. Initial randomized clinical trials indicate possible reductions in craving and substance intake, though GLP-1 Agonists Like Semaglutide Show

Patients with a history of pancreatitis require particular caution, as GLP-1 receptor agonists have been associated with rare cases of acute pancreatitis

AI Statement This manuscript was supported by the use of a large language model (ChatGPT, OpenAI) for language editing and formatting assistance

Gastrointestinal side effects like nausea, fatigue, and digestive discomfort can compound into feelings of irritability or low mood

A separate randomised, double-blind, placebo-controlled trial in type 2 diabetic adults showed a significant increase in postprandial GLP-1 concentration following butyrate supplementation, with a decreasing trend in insulin resistance indices [3]

References: Cani PD et al., 2019 Written by Ali Rza Akn Microbiome Scientist, Author & Founder of Next-Microbiome Ali Rza Akn is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation